Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JenyaD
    Junior Member
    • Mar 2018
    • 2

    #1

    chip-seq data analysis with galaxy

    Hi all! I am very new to this field, so I apologize in advance for my ignorance. I have done several chip-seq experiments on a protein from A.thaliana that functions in homologous recombination. I am struggling a lot with analyzing my data, mostly because I do not completely understand how the tools work. I use galaxy to do the analysis, Bowtie and MACS.

    I have several questions regarding these tools, hopefully someone will help!
    1. I know MACS provides the peak scores as -10log(pvalue) and it gives me ranges usually from 50-3100. But how does MACS2 calculate the score? Using the same dataset, I get very narrow ranges usually in single digits.
    2. What do treatment wig and control wig files show? I read that they show the binding signal, however this explanation is way to vague for me. And how can I correlate the peak bed file to the bigwig file on a genome browser?
    3. When I use MACS to call the peaks, I use default setting (pvalue cutoff 1e-5, and MFOLD value of 32). However, MACS fails everytime since it cannot find enough paired peaks to build the shifting model. Lowering the MFOLD value does not help. Only when I choose not to build the shifting model, only then will MACS succeed in calling the peaks. But, now I am worried, can I trust these peaks that MACS called? If it cannot make a shifting model, how could I predict the location of the binding site? I leave the arbitrary shift size 100 bp, but how do I know if this is the proper value to use? I also read that MACS cannot build the shifting model since there is no defined peaks, this can be a result of broad peaks (like for RNApol), it looks like my peaks are broad as well.

    Thank you for your help!!!!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...